In Vivo Role of NAD(P)H:Quinone Oxidoreductase 1 (NQO1) in the Regulation of Intracellular Redox State and Accumulation of Abdominal Adipose Tissue

This publication has 24 references indexed in Scilit:

• Defective insulin secretion and enhanced insulin action in K _ATP channel-deficient mice
  Proceedings of the National Academy of Sciences, 1998
• Hydroquinones cause specific mutations and lead to cellular transformation and in vivo tumorigenesis
  British Journal of Cancer, 1998
• NAD(P)H:quinone oxidoreductase 1 reduces the mutagenicity of DNA caused by NADPH:P450 reductase-activated metabolites of benzo(a)pyrene quinones
  British Journal of Cancer, 1998
• Disruption of the DT Diaphorase (NQO1) Gene in Mice Leads to Increased Menadione Toxicity
  Journal of Biological Chemistry, 1998
• Chemoprotection against cancer by Phase 2 enzyme induction
  Toxicology Letters, 1995
• NAD(P)H:quinone oxidoreductase1 (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase.
  Proceedings of the National Academy of Sciences, 1994
• DT-diaphorase and cancer chemotherapy
  Biochemical Pharmacology, 1992
• High levels of expression of the NAD(P)H:Quinone oxidoreductase (NQO1) gene in tumor cells compared to normal cells of the same origin
  Biochemical Pharmacology, 1991
• The human dioxin‐inducible NAD(P)H:quinone oxidoreductase cDNA‐encoded protein expressed in COS‐1 cells is identical to diaphorase 4
  European Journal of Biochemistry, 1991
• Mutagenicity of quinones: pathways of metabolic activation and detoxification.
  Proceedings of the National Academy of Sciences, 1984